Regeneron Pharmaceuticals(REGN) · US
Sector: XLV | Last updated: 15 Oct 2026
Regeneron Pharmaceuticals (REGN) is showing Strong Bullish momentum today, with an Altra Score of 90.3 on AltraOne's multi-timeframe (MTF) momentum analysis. The stock is part of the XLV sector, where it ranks 54 by relative strength in a currently bearish RS regime (Relative Strength: 437.06). Recent EMA crossover activity: Close above 8W EMA. REGN closed at 796.34 on 15 Oct 2026 (-0.75% for the day), based on end-of-day (EOD) price data rather than a live quote.
Price
Stock Relative Strength
Latest EMA CrossOvers
REGN's Daily RSI(14) is 59.3 (up 5.0 from prior), Weekly RSI is 57.6 (up 6.3 from prior), and Monthly RSI is 65.5 (up 2.8 from prior). Price is currently trading above its Daily EMA 8, Daily EMA 20, Daily EMA 50, Daily EMA 200, Weekly EMA 8, Weekly EMA 30.
Multi-Timeframe RSI (14)
| Timeframe | RSI | Prev | Change |
|---|---|---|---|
| Daily | 59.3 | 54.2 | ▲ 5.0 |
| Weekly | 57.6 | 51.4 | ▲ 6.3 |
| Monthly | 65.5 | 62.8 | ▲ 2.8 |
Stock Price and EMA Placement
History
TradingView ↗The current active signal for REGN is Bullish, triggered on 03 Aug 2026 at a price of 759.24. Since then, the stock has gained 4.89%.
These are long-term momentum shifts, not buy/sell recommendations.